Cannabis Law Report

JUNE 23, 2021

Exploring Quality of Life Outcomes of Chronic Pain Patients from the UK Medical Cannabis Registry Focused analysis of 190 patients with chronic pain demonstrated improved measures of pain severity and interference at one, three, and six months. Improved quality of life. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Veriheal

JULY 27, 2020

The Sublime Foundation , established by cannabis manufacturing company Sublime Canna, is aimed at helping veterans deal with chronic pain without resorting to opioids. NORML is a cannabis advocacy group that fights for the rights of cannabis users. The Sublime Foundation Helps Veterans.

Research and Development 62

Research and Development Chronic Pain Education Advocacy 62

WeedAdvisor

JULY 3, 2019

According to the survey, 85% of people using or considering cannabis are most likely to consume it for chronic pain. 41% of respondents mentioned neck and back pain as reasons for consumption. WeedAdvisor’s Advocacy for Legalization. . The Gallup Poll also demonstrates the most popular uses for cannabis.

Legalization 60

Legalization Marijuana Chronic Pain Recreational 60

MMJ Recs

OCTOBER 13, 2023

The state established the Medical Cannabis Regulation and Safety Act (MCRSA) in 2015, leading to the creation of the Bureau of Medical Cannabis Regulation and the introduction of a regulatory framework for MMJ dispensaries, cultivators, and manufacturers. Image by Kindel Media on Pexels.

Patients 52

Patients Law Cultivation Dispensary 52

NORML

FEBRUARY 1, 2019

The measure would expand the pool of individuals eligible for medical cannabis by allowing physicians to recommend it to those with generalized chronic pain. Click here to email your lawmakers in support of adding chronic pain to the qualifying medical conditions list. CT resident? NH resident?

Legislation 167

Legislation Decriminalization Access Patients 167

Cannabis Law Report

JUNE 26, 2019

Dr. Weiner is certified in Interventional Pain Management and Physical Medicine and Rehabilitation. She researches substituting cannabis for opioids in chronic pain management at Nova Southeastern University and Florida International University. Heather also acts as a Junior Pain Ambassador with the U.S. Zachary Kobrin.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

Cannabis Law Report

APRIL 12, 2019

I have successfully reduced 85% of my opioid use for chronic pain as the result of arthritis through several surgeries and medical cannabis. Patient advocacy is alive and well in Canada. A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax.

Access 45

Access Patients Marijuana Medicine 45

NORML

FEBRUARY 15, 2019

Also this week Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act, to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions. NH resident? New Mexico.

Legislation 166

Legislation Hemp Compliance Compliance 166

Veriheal

AUGUST 31, 2020

Essay Summary: Maha envisions making a positive social impact on California’s cannabis industry through patient advocacy, cannabis education, social research, and R&D. Maha was the founder and president of UCLA’s first registered cannabis student group, Cannaclub. The club now has 3,000 members nationwide. .

Research and Development 117

Research and Development Education Agriculture Patients 117

NORML

MARCH 22, 2019

Update : HB 1383 was heard and approved by the Committees on Judiciary and Public Safety, Intergovernmental, and Military Affairs on 3/19. Update: SB 5605 is scheduled for a hearing in the House Committee on Public Safety on 3/25 at 1:30pm. The bill was amended to lower the fine from $200 to $30. HI resident? ” IL resident?

Legislation 139

Legislation Hemp Patients Compliance 139

The Cannigma

DECEMBER 12, 2022

Clinical research: Mescaline is not easy to use clinically because of its slow onset and long duration, but clinical trials are being organized for addiction, PTSD, and chronic pain. Iboga safety: Numerous concerns about the safety of iboga have been raised by scientists.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Pain and chronic pain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

NORML

MARCH 29, 2019

Update : HB 1383 was heard and approved by the Committees on Judiciary and Public Safety, Intergovernmental, and Military Affairs on 3/19. Update : SB 5605 recently had a hearing in the House Committee on Public Safety on 3/25, and is scheduled for an executive session in the House Committee on Public Safety on 4/2/2019 at 3:30pm.

Legislation 172

Legislation Decriminalization Hemp Patients 172

NORML

APRIL 29, 2019

The legislation “would direct VA to conduct clinical research with varying forms of medicinal cannabis to evaluate the safety and effects of cannabis on health outcomes of veterans with PTSD and veterans with chronic pain.”

Chronic Pain 209

Chronic Pain Access Medicine Legislation 209

Cannabis Law Report

OCTOBER 20, 2021

s NORML Coordinator Dale Gieringer, Delta-8 has undergone minimal testing in humans, “therefore, little is known about its long-term safety, its consumption at high dosages, or its medicinal effects.” Additionally, the advocacy group views Delta-8 THC as a Schedule I substance under federal law. According to Calif.’s

Hemp 52

Hemp Clinical Trials CBD Legalization 52

The Cannigma

JANUARY 19, 2022

Today on the show we welcome Nikki Lawley, a Traumatic Brain Injury Survivor, and founder of NIKKI and the Plant, an advocacy group for medical marijuana use, with a special focus on helping women who have suffered a TBI. Nikki’s story is deeply inspirational, and we are honored to have had her on the show. Honestly, it was trial and error.

Patients 83

Patients Compliance Compliance Cannabis 83

Freedom Leaf

SEPTEMBER 19, 2019

Aaron Smith, executive director of the National Cannabis Industry Association (NCIA), an advocacy organization working to promote the growth of a responsible and legitimate cannabis industry, believes that the reported illnesses and deaths are a predictable consequence of federal prohibition. And if it tastes terrible, just throw it out. .

Vaping 67

Vaping Packaging Oil Chronic Pain 67

NORML

JANUARY 28, 2019

The negative effects of alcohol abuse, both on the user and their loved ones, are well documented, so it’s odd Stivers and the Kentucky Senate lack the same concern for data and safety when it comes to alcohol.

Data 189

Data Clinical Trials Chronic Pain Medicine 189